Mike Hollan from Pharmaceutical Executive - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Mike Hollan Pharmaceutical Executive Editor at MJH Life Sciences for Pharmaceutical Exec. pharmaceuticalslife sciences		HBA Announces 2024 Woman of the Year - about 1 year ago How Quantum Computing Trends Will Impact Pharma in 2024: Q&A With Erik Huestis, Partner at Foley Hoag - about 1 year ago The Top 5 Q&As of 2023 - over 1 year ago The Top 5 DE&I Stories in 2023 - over 1 year ago Top Marketing Stories of 2023 - over 1 year ago Top 5 AI Stories of 2023 - over 1 year ago The Cover Stories of 2023 - over 1 year ago The Importance of Data in 2024: Q&A With Christoph Bug, Vice President of Global Medical at Veeva - over 1 year ago Finding that Spark - over 1 year ago Clearing Away the Clutter: Implementing Value-Based Contracting in Pharma - over 1 year ago It’s Always Important to Remember: Leaders Make Mistakes - over 1 year ago Market Trends To Watch in 2024: Q&A With Seth Farbman, Chairman and Co-Founder of VStock Transfer - over 1 year ago Mapping the Reproductive Patient Journey: Q&A With David Powley, VP of Reproductive Medicine and Maternal Health and Operations at Ferring Pharmaceuticals - over 1 year ago Reacting to Trends: Q&A With Leslie Orne, CEO of Trinity Life Sciences - over 1 year ago CEO of Trinity Life Sciences Discusses Healthcare Trends and How Companies Are Responding - over 1 year ago Building a Better Toolbox For Patient Enrollment: Q&A With Kimberlee Heidmann, Co-Founder of Scout Clinical - over 1 year ago Piloting New Drug Development: Q&A With Dr. Bruce Leuchter, Ceo of Neurvati - over 1 year ago Piloting New Drug Development: Q&A With Dr. Bruce Leuchter, Ceo of Neuvati - over 1 year ago Getting Proactive About Signal Detection: Q&A With Elizabeth Smalley, Director of Product Management, Data, and Analytics at ArisGlobal - over 1 year ago New Ways to Battle Cancer: Q&A With William Ho, CEO of IN8bio - over 1 year ago Q&A With Jade Shields, Vice President of Corporate Affairs at Ferring Pharmaceuticals - over 1 year ago Fighting Autoimmune Diseases and Developing Leadership Skills Along the Way: Q&A With Dr. Mike McCullar, CEO of RegCell - over 1 year ago Pharma Should Embrace the Single Sign-On - over 1 year ago Fighting Against Antimicrobial Resistance With Phage: Q&A With Jonathan Solomon, CEO of BiomX - over 1 year ago Battling the Cancer Drug Shortage: Q&A With Anshul Mangal, President of Project Farma and Precision Advance - over 1 year ago Q&A With Ramees Raja, Global Energy Manager at Almac Group - over 1 year ago Q&A With Joe Schmidt, EVP, Head of Customer Services and Success at Medidata - over 1 year ago Q&A With Derron Stark, Managing Director of Strategy and Transactions at EY - over 1 year ago Generating Pharma’s AI: Q&A With Masanori Ito, Senior Director, Head of Enterprise Insights and Digital Solutions, Digital, Analytics, and Technology at Astellas - over 1 year ago Raising Funds in a Tight Market: Q&A With Sharon Cunningham, CEO of Shorla Oncology - over 1 year ago 2023 Pharmaceutical Executive APEX Award Winners - over 1 year ago Q&A With Dr. Ronald A. Morton, Chief Medical Officer, Urology, Boston Scientific - over 1 year ago Centered on Decentralized Trials: Q&A With Harpreet Gill, Head of Decentralized Clinical Trials at Icon - over 1 year ago New FDA SaMD Guidance Will Bring Monumental Changes to Industry - over 1 year ago Regulating SaMD: Q&A With David Klein, Co-Founder and CEO of Click Therapeutics - over 1 year ago AmerisourceBergen to Cencora: Q&A with Willis Chandler, President of Global Pharma Services - over 1 year ago Navigating Health Insurance Coverage for Innovative and Specialty Drugs: Q&A With Maria Kirsch, President of Patients Services at EVERSANA - over 1 year ago The Value of Care: Q&A With Peter Rubin, Executive Director at No Patient Left Behind - over 1 year ago